JLK (CEO Dongmin Kim) , a stroke AI specialized company that participated in the International Stroke Conference, said that it felt the hot interest of global medical institutions as many visitors visited its promotional booth.
At the 2025 International Stroke Conference (ISC 2025), held at the LA Convention Center from the 5th to the 7th (local time), a large crowd flocked to the JLK booth. The visitors showed great interest by directly experiencing the stroke AI experience content AI vs. Human prepared by JLK and listening to explanations about medical AI solutions.
From the first day of the exhibition, numerous global medical professionals visited the ISC 2025 exhibition hall, proving that it is the most prestigious international event in the field of stroke. In particular, the JLK booth, which featured the artificial intelligence stroke analysis platform 'MEDIHUB STROKE', was popular.
The AI vs. Human experience zone was filled with medical professionals throughout the event, as they could compare AI and human diagnosis results using actual stroke patient image data. The medical professionals were amazed at JLK’s AI technology’s advancement to the point where it can predict prognosis using stroke image data, and evaluated it as showing the future of AI technology. They also responded positively to the customization technology, which is far more user-friendly than other companies.
In addition, JLK has attracted attention by starting full-scale global sales by intensively promoting stroke AI solutions such as JLK-LVO, JLK-CTP, JLK-PWI, and JLK-ICH, which have already received approval from the US FDA and Japan PMDA.
As global AI technology competition becomes more intense, JLK plans to aggressively attack the market with its unique technological prowess that can lead the global stroke medical AI field.
JLK CEO Dongmin Kim said, “Through this ISC 2025 event, we were able to confirm once again the interest of global medical institutions in stroke AI technology,” and “Through this exhibition, we will further solidify our position as a global leader in the stroke field.”
Meanwhile, ISC 2025 is an academic event co-hosted by the American Heart Association and the Stroke Association, and a research abstract presentation is scheduled for a special session on the 7th on the topic of 'Improving the detection sensitivity of high-difficulty acute cerebral infarction lesions on diffusion-weighted imaging (DWI) using JLK artificial intelligence solution JBS-01K (JLK-DWI)'.
- See more related articles
You must be logged in to post a comment.